Small EJ, Schellhammer PF, Higano CS, et al. Placebo -controlled phase III trial of immunologic therapy with Sipuleucel -T (APC 8015) in patients with metastatic, asymptomatic hor mone refractory prostate cancer. J Clin Oncol 2006; 24: 3089 -94.